XML 20 R13.htm IDEA: XBRL DOCUMENT v3.25.1
Balance Sheet Components
3 Months Ended
Mar. 30, 2025
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components

Note 4. Balance Sheet Components

Available-for-sale investments

Amortized cost and estimated fair market value of investments classified as available-for-sale, excluding cash equivalents, as of March 30, 2025 and December 31, 2024, were as follows:

 

 

 

March 30, 2025

 

(In thousands)

 

Amortized Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

U.S. treasury securities

 

$

119,433

 

 

$

93

 

 

$

 

 

$

119,526

 

Total

 

$

119,433

 

 

$

93

 

 

$

 

 

$

119,526

 

 

 

 

December 31, 2024

 

(In thousands)

 

Amortized Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

U.S. treasury securities

 

$

119,199

 

 

$

171

 

 

$

 

 

$

119,370

 

Total

 

$

119,199

 

 

$

171

 

 

$

 

 

$

119,370

 

The contractual maturities on the U.S. treasury securities as of March 30, 2025 are all due within one year. Accrued interest receivable as of March 30, 2025 was $1.3 million and was recorded within Prepaid expenses and other current assets on the unaudited condensed consolidated balance sheet.

There were no investments classified as available-for-sale in a continuous unrealized loss position for which an allowance for credit losses was not recorded as of March 30, 2025 and December 31, 2024.

In the three months ended March 30, 2025 and March 31, 2024, no unrealized losses on available-for-sale securities were recognized in income. The Company does not intend to sell, and it is unlikely that it will be required to sell the investments in an unrealized loss position prior to their anticipated recovery. There were no other-than-temporary impairments for these

securities during the three months ended March 30, 2025 and March 31, 2024. Refer to Note 12, Fair Value Measurements, for detailed disclosures regarding fair value measurements.

Inventories

 

(In thousands)

 

March 30, 2025

 

 

December 31, 2024

 

Raw materials

 

$

17,437

 

 

$

13,439

 

Finished goods

 

 

140,461

 

 

 

149,100

 

Total

 

$

157,898

 

 

$

162,539

 

 

The Company records provisions for excess and obsolete inventory based on assumptions about future demand and market conditions and the amounts incurred were $1.4 million and $1.1 million for the three months ended March 30, 2025 and March 31, 2024, respectively. While management believes the estimates and assumptions underlying its current forecasts are reasonable, there is a risk that additional charges may be necessary if current forecasts are greater than actual demand.

 

Property and equipment, net

 

(In thousands)

 

March 30, 2025

 

 

December 31, 2024

 

Machinery and equipment

 

$

54,700

 

 

$

54,355

 

Furniture, fixtures, and leasehold improvements

 

 

20,585

 

 

 

20,028

 

Software

 

 

24,737

 

 

 

24,610

 

Computer equipment

 

 

5,393

 

 

 

5,384

 

Total property and equipment, gross

 

 

105,415

 

 

 

104,377

 

Accumulated depreciation

 

 

(94,113

)

 

 

(93,089

)

Total

 

$

11,302

 

 

$

11,288

 

 

Other non-current assets

 

(In thousands)

 

March 30, 2025

 

 

December 31, 2024

 

Non-current deferred income taxes

 

$

2,503

 

 

$

2,332

 

Long-term investments

 

 

8,478

 

 

 

8,381

 

Restricted cash

 

 

2,112

 

 

 

2,107

 

Other

 

 

3,960

 

 

 

3,767

 

Total

 

$

17,053

 

 

$

16,587

 

 

Long-term equity investments

The Company’s long-term investments are primarily comprised of equity investments without readily determinable fair values and investments in limited partnership funds. The carrying value of the equity investments without readily determinable fair values was $6.1 million as of March 30, 2025 and March 31, 2024, respectively. For such equity investments without readily determinable fair value still held at March 30, 2025, there were no cumulative downward adjustments for price changes or impairment, and the cumulative upward adjustments for price changes was $0.3 million. Investments in limited partnership funds amounted to $2.4 million as of March 30, 2025, $2.2 million as of March 31, 2024, $2.3 million as of December 31, 2024, and $2.3 million as of December 31, 2023, respectively.

 

Other accrued liabilities

 

(In thousands)

 

March 30, 2025

 

 

December 31, 2024

 

Current operating lease liabilities

 

$

10,288

 

 

$

10,837

 

Sales and marketing

 

 

50,060

 

 

 

59,129

 

Warranty obligations

 

 

5,307

 

 

 

5,192

 

Sales returns(1)

 

 

27,100

 

 

 

31,711

 

Freight and duty

 

 

4,112

 

 

 

4,979

 

Other

 

 

31,158

 

 

 

36,230

 

Total

 

$

128,025

 

 

$

148,078

 

 

 

(1)
Inventory expected to be received from future sales returns amounted to $12.8 million and $15.1 million as of March 30, 2025 and December 31, 2024, respectively. Provisions to write down expected returned inventory to net realizable value amounted to $8.6 million and $9.0 million as of March 30, 2025 and December 31, 2024, respectively.